Search research articles
Contact Us
Filters
Showing results (81-90 of 201) with videos related to
Page
of 21
Sort By:
Cancer Research
|
March 1, 1983
Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity
D W Fry, L A Anderson, M Borst, et al.
Nanotechnology
|
April 27, 2016
Plasmonic gold nanodiscs fabricated into a photonic-crystal nanocavity
Khalid N Sediq, David Coles, Paul W Fry, et al.
Journal of Medicinal Chemistry
|
July 1, 1986
Basically substituted ellipticine analogues as potential antitumor agents
L M Werbel, M Angelo, D W Fry, et al.
European Journal of Applied Physiology and Occupational Physiology
|
January 1, 1991
Monitoring exercise stress by changes in metabolic and hormonal responses over a 24-h period
R W Fry, A R Morton, P Garcia-Webb, et al.
European Journal of Applied Physiology and Occupational Physiology
|
January 1, 1992
Cell numbers and in vitro responses of leucocytes and lymphocyte subpopulations following maximal exercise and interval training sessions of different intensities
R W Fry, A R Morton, G P Crawford, et al.
Current Opinion in Pediatrics
|
November 12, 2005
Being uninsured: impact on children's healthcare and health
Yvonne W Fry-Johnson, Elvan C Daniels, Robert Levine, et al.
The Journal of International Medical Research
|
January 1, 1976
Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa
J Ximenes, O N Bassoi, J P de Menezes, et al.
Journal of Sports Sciences
|
April 1, 1993
The effects of an acute bout of sleep on running economy and VO2 max
E F Pierce, R W McGowan, E Barkett, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases
A M Thompson, D W Fry, A J Kraker, et al.
Seminars in Oncology
|
November 13, 2003
CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer
Lee F Allen, Irene A Eiseman, David W Fry, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 201) with videos related to
Sort By:
Page
of 21
Cancer Research
|
March 1, 1983
Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity
D W Fry, L A Anderson, M Borst, et al.
Nanotechnology
|
April 27, 2016
Plasmonic gold nanodiscs fabricated into a photonic-crystal nanocavity
Khalid N Sediq, David Coles, Paul W Fry, et al.
Journal of Medicinal Chemistry
|
July 1, 1986
Basically substituted ellipticine analogues as potential antitumor agents
L M Werbel, M Angelo, D W Fry, et al.
European Journal of Applied Physiology and Occupational Physiology
|
January 1, 1991
Monitoring exercise stress by changes in metabolic and hormonal responses over a 24-h period
R W Fry, A R Morton, P Garcia-Webb, et al.
European Journal of Applied Physiology and Occupational Physiology
|
January 1, 1992
Cell numbers and in vitro responses of leucocytes and lymphocyte subpopulations following maximal exercise and interval training sessions of different intensities
R W Fry, A R Morton, G P Crawford, et al.
Current Opinion in Pediatrics
|
November 12, 2005
Being uninsured: impact on children's healthcare and health
Yvonne W Fry-Johnson, Elvan C Daniels, Robert Levine, et al.
The Journal of International Medical Research
|
January 1, 1976
Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa
J Ximenes, O N Bassoi, J P de Menezes, et al.
Journal of Sports Sciences
|
April 1, 1993
The effects of an acute bout of sleep on running economy and VO2 max
E F Pierce, R W McGowan, E Barkett, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases
A M Thompson, D W Fry, A J Kraker, et al.
Seminars in Oncology
|
November 13, 2003
CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer
Lee F Allen, Irene A Eiseman, David W Fry, et al.
Page
of 21